Schedule 13G ownership disclosure

Indivior Pharmaceuticals Inc

Security class unavailable · CUSIP: 04546C106

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
980,253
Percent of class
2.1500%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001163648-22-000002
Form type
SC 13G/A
Filer
Assertio Holdings, Inc.
CIK
CIK 1808665
Filed
Feb 10, 2022
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub